Advocacy News

The ACR is your source for advocacy news impacting your practice, patients, and the rheumatology subspecialty. In addition to staying on top of ever changing policies and political landscapes for our members, we are often invited to give statements, provide comments, or work with lawmakers to promote new policies.

For the most up to date news regarding ACR advocacy efforts, be sure to follow @ACRheumDC on Twitter.

Advocacy Accomplishments

See a summary of ACR's advocacy efforts in the 2020 Advocacy Year in Review.

Advocacy Priorities

See an overview of the ACR’s 2021 Advocacy Priorities for the U.S. Congress, federal agencies, and state governments.

Press and Public Statements

View the latest rheumatology news, including press releases and public statements about current advocacy issues affecting ACR and ARP membership in the Newsroom.

ACR@Work Newsletter

The ACR publishes a bimonthly electronic newsletter for members with the latest news and activities relating to advocacy and policy updates, practice management, insurance issues, and more. See the latest issues.

September 9, 2021 - Tocilizumab Allocation Guidance, First State Loan Forgiveness & More

August 26, 2021 - COVID-19 Vaccine Boosters, Efficacy in Immunosuppressed Patients & More

August 12, 2021 - Advocate at Home in August, Most Favored Nation Rescinded & More

July 22, 2021 - The ACR's Take on the PFS Proposed Rule, Learn to Raise Your Voice & More

July 8, 2021 - Become an Advocate for Arthritis, Regulating PBMs & More

June 24, 2021 - ACR Resolution Passes AMA House of Delegates, DXA Bill & More

June 10, 2021 - Prior Authorization Bill, Informing Relative Value & More

Social Media

Be sure to follow the ACR on Facebook, Twitter, and LinkedIn. For advocacy specific updates, follow @ACRheumDC on Twitter. ACR often interacts with lawmakers, posts pictures, circulates articles, and more. Get engaged and join the conversation.

© 2021 American College of Rheumatology.  All rights reserved.  Website & Privacy Policies | Sitemap | Help | Contact Us